News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Domain Therapeutics unveils DT-9045, a groundbreaking PAR2 NAM candidate, for potential advancements in cancer treatment
Tuesday, June 06, 2023Domain Therapeutics a clinicalstage biopharmaceutical company focused on immunooncology drugs that target G ProteinCoupled Receptors GPCRs has announced the selection of its latest drug candidate DT This candidate is a Negative Allosteric Modulator N...
ANeuroTech's ANT-01, an Adjunctive Anti-Depression Drug, Receives FDA IND Approval for Pivotal Phase IIIB Trial
Tuesday, June 06, 2023ANeuroTech a pioneering company in the field of mental health treatments with minimal or no side effects has received approval from the US Food and Drug Administration FDA to begin a pivotal Phase IIIB trial of their drug ANT This trial will investig...
VaxEquity and CPI Secure Innovate UK Grant to Accelerate Advancements in Next-Generation RNA Vaccines and Therapeutics
Monday, June 05, 2023VaxEquity and CPI have received a grant of approximately K from Innovate UK to collaborate on a project focused on enhancing the manufacturing process for RNA vaccines and therapeutics Their goal is to optimize the scalability of selfamplifying RNA s...
BioNTech and OncoC4 Present Promising Phase 1/2 Findings for BNT316/ONC-392 Antibody Candidate in Hard-to-Treat NSCLC at ASCO
Saturday, June 03, 2023BioNTech SE Nasdaq BNTX and OncoC Inc recently released positive preliminary data from their Phase trial involving BNTONC an antiCTLA antibody candidate for the treatment of metastatic PDLresistant nonsmall cell lung cancer NSCLC
Astrea Bioseparations joins Biotage, enabling groundbreaking chromatography solutions
Friday, June 02, 2023Biotage has completed the acquisition of Astrea Bioseparations a highgrowth chromatography solutions provider from Gamma Biosciences a life sciences tools platform created by KKR
REALM IDx Introduces REALM Pharma Services to Enhance Drug Development and Research
Friday, June 02, 2023REALM IDx made an announcement today regarding the introduction of REALM Pharma Services This new service aims to provide a complete solution for biotechnology and pharmaceutical partners covering discovery translational research and clinical trial s...
Phase 3 Clinical Trial Approval for YS Biopharma's PIKA Rabies Vaccine Granted by Philippines FDA
Friday, June 02, 2023YS Biopharma Co Ltd NASDAQ YS has announced that its PIKA Rabies Vaccine has received Phase clinical trial approval from the Food and Drug Administration of the Philippines The vaccine is being developed by YS Biopharma a global biopharmaceutical co...
Impact Therapeutics and Eikon Therapeutics Collaborate Globally to Develop and Commercialize PARP1 Selective Inhibitors
Friday, June 02, 2023IMPACT Therapeutics and Eikon Therapeutics have recently announced a global license and collaboration agreement for the development of PARP selective inhibitors including IMP IMPACT Therapeutics is a biopharmaceutical company focused on discovering a...
Caris Life Sciences and ConcertAI Forge an Expanded Partnership to Develop a Pioneering Clinico-Genomic Research Platform Enabling Prospective Patient Matching
Friday, June 02, 2023Caris Life Sciences and ConcertAI have recently announced an expanded partnership in the field of translational sciences and clinical development solutions The companies aim to collaborate on the creation of a comprehensive database of molecular clin...
European Approval Granted to Novartis' Cosentyx® as the First and Only IL-17A Inhibitor for Hidradenitis Suppurativa
Friday, June 02, 2023Novartis has announced that the European Commission EC has approved Cosentyx secukinumab for the treatment of active moderate to severe hidradenitis suppurativa HS in adults who have not responded well to conventional systemic HS therapy This approva...
